Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)
Launched by UNIVERSITY OF OREGON · Mar 1, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Preventing School Exclusion and Opioid Misuse" is studying a program called the Inclusive Skill-building Learning Approach (ISLA) to see if it can reduce the use of suspensions and expulsions in schools, improve how teachers teach, and help students avoid misusing substances like opioids. This research will take place in 60 middle schools across six states and will involve both teachers and students.
To participate, teachers at these schools need to regularly interact with students, and all educators will be involved in the program activities. For students, the focus is on those in Grade 7 during the first year of the program. They will be followed into Grade 8 to see how the program affects their behavior and outcomes. The trial aims to collect data through surveys from participating educators and students over two years, and students who are in Grade 6 at the start of the study may also be randomly selected to contribute additional information. It's a great opportunity to be part of a project that seeks to create a more supportive school environment while addressing substance misuse among young people.
Gender
ALL
Eligibility criteria
- • Teachers: The educator sample will include all educators within each of the schools. All educators that have regular contact with students (e.g., administrators, teachers, instructional assistants, school counselors) will participate in the school-wide ISLA intervention activities. All educators at both treatment and control schools, if they consent, will provide data through an annual survey administered at three time points: in the spring prior to the first year of ISLA implementation (baseline), in the spring of the first year of ISLA implementation (post-intervention), and in the spring of the second year of ISLA implementation (follow-up).
- * Inclusion criteria:
- • \* Staff member in either a control or intervention condition school
- * Exclusion criteria:
- • None
- • Cohort Students: The student cohort sample will include all students in Grade 7 during the first year of ISLA implementation, who will be followed into Grade 8 during the second year of ISLA implementation (such that data can be collected from the end of Grade 6 to the end of Grade 8). With an average middle school size of 660 students per school, we project the cohort size to be 220 students per school, for a total of 11,880 to 13,200 students.
- • Sub-cohort Students: A random sample of 50 assenting 6th grade students (at the time of baseline data collection) per cohort per school will be selected to provide additional data, for a total of 2,700 to 3,000 students (consent will be gathered from parents/guardians). With the help of each school administrator, the research team will conduct the randomization process using each school's enrollment. School administrators will invite all 6th grade students to participate via recruitment emails to their parents/guardians. A random selection of students will be made from those parents who are consented.
- * Inclusion Criteria:
- • \* 6th grade students in either intervention or control schools during first data collection period for each wave
- * Exclusion Criteria:
- * students who cannot complete the online survey independently (e.g., require assistance beyond text-to-speech files to comprehend the items and available responses) specifically:
- • students who cannot comprehend written or spoken English or written or spoken Spanish, or
- • students who are eligible for alternate assessment for statewide achievement testing.
About University Of Oregon
The University of Oregon is a leading research institution dedicated to advancing scientific knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including psychology, neuroscience, and public health, to conduct rigorous studies that address critical health challenges. Committed to ethical research practices and participant welfare, the University of Oregon fosters an environment of academic excellence, driving forward the discovery of new treatments and interventions that enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Capitola, California, United States
Yuba City, California, United States
Salem, Oregon, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported